Quarterly report [Sections 13 or 15(d)]

Income (Loss) Per Common Share - Schedule of Income (Loss) Per Common Share, Basic and Diluted (Details)

v3.25.3
Income (Loss) Per Common Share - Schedule of Income (Loss) Per Common Share, Basic and Diluted (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Net loss available to stockholders $ (2,130,947) $ (930,408) $ (4,254,974) $ (3,574,171)
Weighted average shares outstanding - basic (in shares) 28,817,040 24,850,261 26,354,875 24,850,261
Stock options        
Weighted average shares outstanding - Diluted (in shares) 28,817,040 24,850,261 26,354,875 24,850,261
Basic loss per share (in usd per share) $ (0.07) $ (0.04) $ (0.16) $ (0.14)
Diluted loss per share (in usd per share) $ (0.07) $ (0.04) $ (0.16) $ (0.14)
Stock Options        
Stock options        
Stock options (in shares) 0 0 0 0
Anti-dilutive shares underlying stock options outstanding 243,836 1,726,086 244,836 1,726,086